MedTrace Logo

Mifepristone and Misoprostol for Midtrimester Termination of Pregnancy in Uzbekistan

NCT02235155 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 135

Last updated 2016-01-14

No results posted yet for this study

Summary

The primary goal is to examine the efficacy and feasibility of a mifepristone-misoprostol medical abortion regimen in terminating pregnancies 13-22 weeks in Uzbekistan.

Conditions

  • Abortion in Second Trimester

Sponsors & Collaborators

  • Gynuity Health Projects

    lead OTHER

Principal Investigators

  • Dilfuza Kurbanbekova, PhD, MD · Women's Wellness Center, Uzbekistan

  • Tamar Tsereteli, PhD, MD · Gynuity Health Projects

  • Beverly Winikoff, MD, MPH · Gynuity Health Projects

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-11-30
Completion
2015-11-30

Countries

  • Uzbekistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02235155 on ClinicalTrials.gov